These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 30232239)

  • 61. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.
    Li J; Butcher J; Mack D; Stintzi A
    Inflamm Bowel Dis; 2015 Jan; 21(1):139-53. PubMed ID: 25248007
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease.
    Shapiro JM; de Zoete MR; Palm NW; Laenen Y; Bright R; Mallette M; Bu K; Bielecka AA; Xu F; Hurtado-Lorenzo A; Shah SA; Cho JH; LeLeiko NS; Sands BE; Flavell RA; Clemente JC
    Cell Host Microbe; 2021 Jan; 29(1):83-93.e3. PubMed ID: 33385335
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Helminths and Intestinal Flora Team Up to Improve Gut Health.
    Giacomin P; Agha Z; Loukas A
    Trends Parasitol; 2016 Sep; 32(9):664-666. PubMed ID: 27234811
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure.
    Nardone OM; de Sire R; Petito V; Testa A; Villani G; Scaldaferri F; Castiglione F
    Front Immunol; 2021; 12():694217. PubMed ID: 34326845
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The multifaceted role of commensal microbiota in homeostasis and gastrointestinal diseases.
    Silva MJ; Carneiro MB; dos Anjos Pultz B; Pereira Silva D; Lopes ME; dos Santos LM
    J Immunol Res; 2015; 2015():321241. PubMed ID: 25759839
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gut Microbiota and Alimentary Tract Injury.
    Chen Y; Wu G; Zhao Y
    Adv Exp Med Biol; 2020; 1238():11-22. PubMed ID: 32323177
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An integrative view of microbiome-host interactions in inflammatory bowel diseases.
    Wlodarska M; Kostic AD; Xavier RJ
    Cell Host Microbe; 2015 May; 17(5):577-91. PubMed ID: 25974300
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Interaction between humans and intestinal bacteria as a determinant for intestinal health : intestinal microbiome and inflammatory bowel diseases].
    Haller D; Hörmannsperger G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Feb; 58(2):159-65. PubMed ID: 25566836
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of the gut and microbes in the pathogenesis of spondyloarthritis.
    Asquith M; Elewaut D; Lin P; Rosenbaum JT
    Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):687-702. PubMed ID: 25488778
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inflammatory Bowel Diseases and Gut Microbiota.
    Haneishi Y; Furuya Y; Hasegawa M; Picarelli A; Rossi M; Miyamoto J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835245
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Microbiota-antibody interactions that regulate gut homeostasis.
    Weis AM; Round JL
    Cell Host Microbe; 2021 Mar; 29(3):334-346. PubMed ID: 33705705
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Changes of intestinal microbiota and microbiota-based treatments in IBD.
    Li Q; Zhou S; Wang Y; Cong J
    Arch Microbiol; 2022 Jul; 204(7):442. PubMed ID: 35776212
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inflammatory Bowel Disease Environmental Risk Factors: Diet and Gut Microbiota.
    Altajar S; Moss A
    Curr Gastroenterol Rep; 2020 Oct; 22(12):57. PubMed ID: 33044636
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets.
    Tie Y; Huang Y; Chen R; Li L; Chen M; Zhang S
    Gut Microbes; 2023 Dec; 15(2):2265028. PubMed ID: 37822139
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
    Mishima Y; Sartor RB
    J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Factors responsible for the modulation of microbiota and their impact on course of inflammation in inflammatory bowel disease – selected aspects].
    Fabisiak N; Fichna J
    Postepy Biochem; 2023 Mar; 69(1):54-62. PubMed ID: 37493556
    [TBL] [Abstract][Full Text] [Related]  

  • 78. How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology.
    Frosali S; Pagliari D; Gambassi G; Landolfi R; Pandolfi F; Cianci R
    J Immunol Res; 2015; 2015():489821. PubMed ID: 26090491
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
    Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
    Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Intestinal Microbiota in Inflammatory Bowel Disease.
    Becker C; Neurath MF; Wirtz S
    ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.